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Summary
Gamma-butyrolactone signalling molecules are pro-
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lactone (SCB1) has been shown to stimulate antibiotic
production, and genes encoding proteins that are









have been characterized. Expression of these genes





-butyrolactone. In this study, additional genes
influenced by ScbR were identified by DNA microar-
ray analysis, and included a cryptic cluster of genes
for a hypothetical type I polyketide. Further analysis





, is a direct target for regulation
by ScbR. Gel retardation and DNase I footprinting
analyses identified two potential binding sites for
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butyrolactone-binding protein directly regulates a








Streptomycetes are morphologically complex Gram-
positive mycelial soil bacteria that produce a variety of
secondary metabolites. Many of these metabolites have
antibiotic activity, and some are of great commercial
value. They are typically products of intricate biosynthetic
pathways that are activated in a growth phase-dependent
manner, so that production coincides with the onset of
aerial mycelium formation in agar-grown cultures and with
stationary phase in liquid (Champness, 2000). This
expression pattern is often mediated by pathway-specific








., 1993). Many streptomycetes





that play important regulatory roles in the onset of
antibiotic production and, sometimes, of morphological




-butyrolactone  discovered,  and  the  best  character-
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include the virginiae butanolides (VB), which control vir-
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 A3(2), genetically the most characterized























, and the structure of one of these molecules,









, A-factor accumulates to detectable levels
in the culture medium before the onset of streptomycin
production and binds to a cytoplasmic A-factor-binding




., 1995). In the absence of A-





, repressing its transcription; and as
AdpA directly activates transcription of the pathway-
specific activator gene for streptomycin biosynthesis,
streptomycin is not produced. In the presence of A-factor,















and its cognate-binding protein have been reported in

























., 1997). BarA (which shows higher similar-










., 1997). The exact role of BarB is not
known, although it is thought to be part of the BarA reg-


















































From mutagenesis studies and promoter expression anal-
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ysis, ScbR was found to repress its own expression while









produced two quite different antibiotics (Act and Red –









 mutant was delayed in Red production (Takano
 
et al., 2001). Surprisingly, these phenotypes were the
opposite  of  those  expected  from  the  A-factor  model  in
S. griseus.
The results presented here used DNA microarray
analysis as a guide to identify another direct target of
ScbR,  and  thus  further  extended  the  knowledge  of  the
g-butyrolactone regulatory cascade in S. coelicolor. The
new target is part of a cryptic polyketide gene cluster, first
identified by Kuczek et al. (1997), that lies very close to
scbA and scbR on the chromosome (Bentley et al., 2002).
ScbR was shown to interact directly with the promoter
region of kasO, which encodes a SARP homologue, and
binding was prevented by the addition of SCB1. Further-
more, a kasO deletion mutant was constructed, and the
expression of some genes in the cryptic polyketide gene
cluster was analysed by reverse transcription polymerase
chain reaction (RT-PCR). The expression of these genes
was markedly reduced or undetectable in the mutant com-
pared with the parent strain, suggesting that kasO is
indeed an pathway-specific regulatory gene.
Results
Microarray analysis reveals several genes that are 
repressed (directly or indirectly) by ScbR
ScbR is an autorepressor, as shown by several observa-
tions: transcription from the scbR promoter is highly ele-
vated at early exponential phase in an scbR null mutant
(M752); ScbR binds to the scbR promoter; and the addi-
tion of exogenous SCB1 g-butyrolactone to M751 (DscbA)
induces the expression of scbR dramatically, and pre-
vents binding of ScbR to the scbR promoter region
(Takano et al., 2001). To identify other genes that might
be repressed by ScbR, we used newly available glass
slide microarrays spotted with PCR products correspond-
ing to 7333 of the 7825 annotated genes identified by
genome sequencing of the M145 strain of S. coelicolor
A3(2) (Bentley et al., 2002; Chater et al., 2002). RNA was
isolated from replicate cultures of M145 and its scbR-
deleted derivative M752 at OD450 0.5 (14.0 h) and 0.46
(14.0 h) from growth curve No. 1 (GC1), and OD450 0.38
(15.5 h) and 0.37 (15.5 h) from growth curve No. 2 (GC2),
respectively, in supplemented liquid minimal medium
(SMM). Both strains grew at the same rate. RNA was also
isolated from replicate mid-exponential phase cultures of
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an scbA-deleted derivative of M145 (M751) immediately
before (time 0) and 60 min after the addition of chemi-
cally synthesized SCB1 (final concentration of 31 ng
ml-1 = 128 mM). For the microarray experiment with the
scbR mutant, gene expression in the mutant was com-
pared with that of the wild type at early exponential
phase, as genes regulated by ScbR are strongly
repressed at this stage in the wild type. Data analysis
using GeneSpring (Silicon Genetics) revealed 15 genes
with higher expression in M752 than in M145 and 13
genes with higher expression in M751 after addition of
SCB1 (Table 1). The genes included scbR in the SCB1
addition experiment, as predicted from our previous
experiments. The general reliability of the data and the
quality of the RNA were supported by S1 nuclease pro-
tection analysis of the growth stage-specific genes, scbR
and scbA and of a constitutively expressed gene, hrdB,
that encodes the major sigma factor of S. coelicolor (data
not shown). The microarray data on the expression of
three of the genes listed in Table 1 were also analysed by
Table 1. Gene whose transcripts were found to be more abundant in the scbR mutant (M752) than in the parent (M145) (a) and after the addition
of SCB1 to the scbA mutant (M751) (b). Primary array data can be found in the supplement.
Gene No. (cosmid-based gene No.)a Ratiob P-valuec Descriptiona
(a) Genes overexpressed in the 
scbR mutant (M752)
SCO6277 (SC1G7.03) 20.2 0.0402 Epoxide hydrolase
SCO6283 (SC1G7.09) 9.45 0.0341 Conserved hypothetical protein
SCO6278 (SC1G7.04) 6.72 0.0464 Integral membrane transport protein
SCO6281 (SC1G7.07) 3.75 0.0212 FAD-binding protein
SCO6284 (SC1G7.10) 3.05 0.0763 Putative decarboxylase
SCO6269 (SCAH10.34c) 2.83 0.00961 orfY oxidoreductase beta-subunit
SCO6279 (SC1G7.05) 2.79 0.0231 Diaminobutyrate-pyruvate aminotransferase
SCO4646 (SCD82.17) 2.64 0.0197 secE preprotein translocase SecE subunit
SCO1244 (2SCG1.19) 2.34 0.0246 bioB biotin synthase
SCO6272 (SC2C4.02) 2.21 0.0427 Secreted FAD-binding protein
SCO5225 (SC7E4.22c) 1.87 0.00364 nrdM ribonucleotide-diphosphate reductase small chain
SCO3767 (SCH63.14) 1.74 0.00392 Hypothetical protein
SCO4253 (SCD8A.26c) 1.52 0.00941 Unknown
SCO4703 (SCD31.28) 1.50 0.0137 rplD 50S ribisomal protein L4
SCO3534 (SCE2.15) 1.46 0.0130 Large ATP-binding protein
(b) Genes overexpressed in M751 
(DscbA) upon addition of SCB1
SCO6281 (SC1G7.07) 15.5 0.0169 FAD-binding protein
SCO6278 (SC1G7.04) 14.6 0.0117 Integral membrane transport protein
SCO6283 (SC1G7.09) 13.4 0.0136 Conserved hypothetical protein
SCO6277 (SC1G7.03) 12.8 0.0164 Epoxide hydrolase
SCO6286 (SC1G7.12c) 7.40 0.0512 Regulatory gene
SCO6282 (SC1G7.04) 7.35 0.0240 Oxidoreductase
SCO6273 (SC2C4.03) 5.23 0.0491 Putative type I polyketide synthase
SCO6275 (SC1G7.01c) 4.75 0.0525 Putative type I polyketide synthase
SCO6272 (SC2C4.02) 4.61 0.0488 Secreted FAD-binding protein
SCO6265 (SCAH10.31) 4.38 0.0484 scbR g-butyrolactone-binding protein
SCO6276 (SC1G7.02) 4.25 0.0488 Secreted protein
SCO6267 (SCAH10.32) 3.99 0.0622 Hypothetical protein (orfA)
SCO1244 (2SCG1.19) 3.15 0.00728 bioB biotin synthase
a. The SCO numbers are taken from the EMBL Accession No. AL645882. Cosmid-based gene numbers are also given in brackets. The
description of each gene is based on the genome annotation in AL645882.
b. Normalized average ratio of signals from M752 versus M145 for time point 1 (a) and from M751 time zero versus 60 min after addition of
SCB1 for (b).
c. t-test P-value calculated from replicate data.
Fig. 1. S1 nuclease protection analysis of three genes identified by 
the microarray analysis to be overexpressed in the scbR mutant. 
Transcription of SCO6283, SCO6272 and SCO3534 was analysed by 
S1 nuclease protection experiments using RNA isolated from M145 
and scbR GC1 at time point 1, OD450 0.36 and 0.39 (M145: 15.5 h, 
M752: 15.5 h), respectively, and also RNA isolated from DscbA at 
OD450 0.41 just before (–) and 60 min after addition of SCB1 (+).
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S1 nuclease protection analysis (Fig. 1). Transcripts of all
three genes (SCO6283, SCO6272 and SCO3534) were
confirmed to be dramatically more abundant in the scbR
mutant than in the parent strain and all three were
strongly induced when SCB1 was added to the scbA
mutant. Primary array data can be found in the
supplement.
The expression of genes that could be involved in Act
or Red regulation or biosynthesis was not observably
increased at the time point studied in this DNA microarray
analysis. This resulted from the scbR mutant antibiotic
production phenotype: it is repressed in Act production,
and Red production had not yet occurred at the time when
the RNA was isolated.
None of the genes identified by microarray analysis to be 
overexpressed in a scbR mutant appear to be directly 
regulated by ScbR
Previously, we showed that ScbR in a crude cell-free
extract from an Escherichia coli-based expression sys-
tem could form DNA–protein complexes with the scbA/
scbR promoter region, as detected by gel retardation
(Takano et al., 2001). To test whether ScbR directly regu-
lates the genes identified by microarray analysis, similar
gel retardation experiments were conducted using Dig-
labelled PCR products corresponding to the regions
upstream of most of these genes (Table 2). Genes with
coding start sites overlapping the preceding genes
(SCO6273, 6277 and 6278) were omitted from the gel
retardation analysis as it is likely that these genes are co-
transcribed with the gene upstream. In no case was
there evidence of the formation of DNA–protein com-
plexes (data not shown), suggesting that the sequences
upstream of these genes were not direct targets for ScbR
binding, although it could not be excluded that other
accessory factors might be needed for binding in any
particular case.
In the absence of SCB1, ScbR binds to the promoter 
region of the possible pathway-specific regulatory gene 
kasO of the polyketide cluster containing most of the 
ScbR-regulated genes
Many genes identified by the transcriptome analysis are
located in a cryptic polyketide gene cluster (Kuczek
et al., 1997; K. Pawlik et al., in preparation) (Fig. 2). The
structure of the end product of this biosynthetic pathway
has not yet been determined, but the sequence indi-
cates the involvement of a multimodular type I
Table 2. List of primers used to create PCR fragments for gel retardation experiments.
Primers Primer sequence 5¢-3¢a Template Fragment sizeb (bp) Amplified promoter regionc
accA1F cagggcgaacgcctcatcagc SC2C4 504 SCO6271/6272 (accA1/scF)
accA1R gacaccgcggcgcctttcatg
ksEF ctcgatcgagtggaccgtctc SC1G7 502 SCO6282/6283
ksER ggatcgccgtcgttctggacg
G119F gcagaacccggccagttcgct Total DNA 510 SCO1244
G119R caggtcgtcgtcggaagtgac
ksRF ctgctaatggccgtactgacc Total DNA 268 SCO6279
ksRR gcagaaacggctcggcgaagc
ksFF tagctactgcgcctccacaag Total DNA 268 SCO6281
ksFR cgacggcaccgtgtctgatga
secEF gatcatccggtgcacaccaag SCD82 333 SCO4646 (secE)
secER ccttcttgcctcgcttgccgc
orfYF acgtcatgtcctcgagccggta Total DNA 115 SCO6269 (orfY)
orfYR agtccttcatggactgcttgc
ksSF gacagtcccacgacagcgatc SC1G7 502 SCO6275/6276
ksSR gtgacgttcgcgaaggtctcg
ksTF cgctcaccaccgaggagttca SC1G7 425 SCO6284
ksTR catggtcacgggcagggaacc
ksNF acttctatctcgaccagagcg SC1G7 372 SCO6288
ksNR cgagtgtctggcagaccttgg
R2Fw2 gtcgaactcgggcgtcagctc SC1G7 430 SCO6286/6287
R2Rev cctcggcggcggagagaat
F gtgtatgtcacggacgaggag SC1G7 522 SCO6280 (kasO)
R gttggcctgcaacagcaggta
A1 gcaaggactgctcgccggaca SC1G7 259 SCO6280 (kasO)
A2 ctcagggtcaccgacgctccg
3 ccctccggagcgtcggtgacc SC1G7 201 SCO6280 (kasO)
4 ggaggccgcgctgcgcgacgt
a. 5¢ to 3¢ primer sequences. Bold represent tails added to the original sequence.
b. Size of PCR amplified product.
c. Description of the amplified promoter region. The SCO numbers are taken from the EMBL Accession No. AL645882. Gene names are also
given in brackets. In some cases where two genes are divergent to each other, both gene names are given.
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polyketide synthase. The fact that we could not obtain
evidence of direct binding of ScbR to the regions
upstream of these genes (which include the promoter
region of one putative regulatory gene SCO6286) sug-
gested that the direct target of ScbR might be one or
both of the two other putative regulatory genes present
in the polyketide gene cluster: SCO6280 (kasO) and
SCO6288, which encode homologues of SARPs (Wiet-
zorrek and Bibb, 1997). The expression level of
SCO6288 was too low for reliable microarray analysis,
and no data were obtained for the other putative path-
way-specific regulatory gene, kasO, because a PCR
probe for this gene was not available on the microarray.
Gel retardation experiments were conducted to assess
whether ScbR could directly regulate these two regula-
tory genes.
A DNA–protein complex was observed with the kasO
promoter fragment (fragment F+R) (Fig. 3A and B), but
not with the SCO6288 promoter fragment (data not
shown). We also failed to detect complexes with the pro-
moters of SCO6271 and SCO6287, putative biosynthetic
genes that had not been highlighted in the microarray
analysis. Three retarded kasO promoter bands were visi-
ble at different dilutions of the ScbR protein, suggesting a
possibility of two binding sites within the DNA used for the
gel retardation experiment. The kasO promoter fragment
showed no retardation with an equivalent concentration of
ScbR-free extract isolated from E. coli JM101. Addition of
100- to 10-fold excess of unlabelled specific PCR product
reduced the proportion of the labelled promoter-contain-
ing fragment that was fully retarded. No competition was
apparent when 100-fold excess unlabelled non-specific
Streptomyces DNA (the vector plasmid pIJ922) was
added. These results indicated a specific interaction
between ScbR and the kasO promoter region.
In previous work (Takano et al., 2001), we showed that
SCB1, the g-butyrolactone produced by S. coelicolor,
could prevent binding of ScbR to the scbA and scbR
promoters. Based on this observation, SCB1 and each of
its three chemically synthesized stereoisomers were
added to the gel retardation assays. Formation of the
DNA–protein complex was reduced upon addition of 1 mg
(1.6 mM) of SCB1, whereas the addition of equivalent
amounts of each stereoisomer of SCB1 had little or no
effect (Fig. 3C). In the case of VB type CD+, the effect
was very similar to SCB1 in Fig. 3C; however, with
repeated experiments the level of relief was less than
obtained with the same amount of SCB1 (data not
shown). This indicated that ScbR has a high level of spec-
ificity for its cognate g-butyrolactone, and that SCB1 pre-
vents DNA binding activity by ScbR.
In confirmation of the presence of two ScbR binding
sites in the kasO promoter region, two smaller DNA frag-
ments, kasOA1+A2 (259 bp) and kas3+4 (201 bp), both
showed ScbR binding in gel retardation experiments
(Fig. 3D). No competition was apparent when 100-fold
excess unlabelled pIJ922 (non-specific competitor) was
added, indicating that the interactions between ScbR and
the two kasO promoter regions were specific. Addition of
1 mg (1.6 mM) of SCB1 reduced DNA–protein complex
formation in both promoter regions, slightly more effec-
tively with the kasOA1+A2 fragment, suggesting that
SCB1 prevents DNA binding by ScbR, in agreement with
previous results (Takano et al., 2001).
Fig. 2. Genetic organization of DNA near scbA and scbR (SCO6264–SCO6289). Genes are represented by shaded arrows. Numbers denote 
SCO gene numbers from the S. coelicolor genome sequence (EMBL Accession No. AL645882). Genes identified to be induced in the scbR 
mutant by microarray analysis are indicated in bold. The promoter regions analysed for binding to ScbR by gel retardation experiments are 
indicated in shaded circles. The genes represented by the cosmids are underlined, with the cosmid numbers indicated below.
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The ScbR binding sites identified by DNase I 
footprinting analysis
The putative transcriptional start site of kasO was deter-
mined by high resolution S1 nuclease protection analysis
to be 35 nt upstream of the kasO translational start site
(Fig. 4A). The putative -10 and -35 regions of the kasO
promoter resemble the consensus sequence for the
major and essential sigma factor HrdB (Brown et al.,
1992).
DNase I footprinting was used to locate the DNA bind-
ing sites of ScbR in the kasO promoter region. Two
protected regions were identified (Fig. 4B). Site OA lies
at -3 nt to -34 nt from the kasO transcriptional start site
and site OB at -222 nt to -244 nt (Fig. 4C). Site OA over-




A Fig. 3. Binding of ScbR to the kasO promoter region.
A. kasO promoter fragments used for gel retar-
dation and DNase I protection experiments. 
The name of the primers are in the order of the 
positions of the primers. The arrow (kasOp) 
denotes the potential transcriptional start site of 
kasO. The dotted line denotes the ScbR binding 
sites explained in more detail in Fig. 5C.
B. Gel retardation experiments with crude 
extract of E. coli JM101 harbouring scbR, vari-
ous controls. The numbers denote the various 
amounts (ml) of 8¥ diluted JM101/scbR crude 
extract used. One microlitre of concentrated (8¥ 
that of ScbR) E. coli JM101 crude extract was 
used for the negative control.
C. Gel retardation experiments using crude 
extract of JM101 harbouring scbR (2.5 ml of 8¥ 
diluted) and supplemented with SCB1 or one of 
its three stereoisomers. CD (Circular Dichro-
ism) denotes the optical rotation (+ or –) of each 
g-butyrolactone.
D. Gel retardation experiment using smaller 
DNA fragments containing either of the two 
ScbR binding sites with various controls. 2.5 ml 
of 8¥ diluted E. coli JM101 harbouring scbR 
was used for each reaction. Quantities used in 
controls were as in Fig. 4B.
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Fig. 4. S1 nuclease transcript mapping and DNase I protection analysis of the kasO promoter region.
A. High resolution S1 nuclease protection analysis of the transcriptional start site of kasO. An asterisk indicates the probable start site; the 
sequences shown are those of the template strand. Lanes G, A, T and C are sequence ladders derived from the same labelled primers that were 
used to generate the PCR products.
B. DNase I protection analysis. The regions that are protected from cleavage by DNase I are shown by vertical lines. Site A covers the −10 and 
−35 regions of the kasO promoter, whereas site B lies further upstream from site A. Opposite DNA strands were assessed for protection by 
separately labelling each of the oligonucleotides used to generate the PCR product. G, A, T and C ladders were used to locate precisely the 
protected regions.
C. Sequence of the kasO promoter region showing the ScbR binding sites. Sequences protected by ScbR from DNase I cleavage are indicated 
in bold; numbering is with respect to the kasO transcriptional start site, which is shown by an arrow. Presumptive −10 and −35 regions of the 
kasO promoter are underlined. An inverted repeat sequence is shown with underscored arrows. A somewhat similar sequence in site OB (but 
with different spacing) is also underlined.
D. Consensus ScbR binding sequence. Four ScbR binding sites are compared for a binding consensus sequence. Two sites (bold) have a very 
conserved consensus inverted repeat sequence while the other two do not. The predicted ScbR binding consensus sequence is in bold italics. 
The ArpA binding consensus sequence and the BarA, FarA binding consensus sequence are also indicated. Note that a differently spaced 
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resembles one of the previously identified ScbR targets,
site R from the scbA/R promoter region (Fig. 4D; Takano
et al., 2001). The consensus sequences found in the
ArpA, BarA and FarA binding sites (Kinoshita et al., 1997;
Onaka and Horinouchi, 1997) also show some similarity
(Fig. 4D). Site OB of the kasO promoter also had palin-
dromic sequences somewhat similar to the consensus,
but with a 4 bp greater spacing.
kasO is temporally expressed in M145, and is repressed 
by ScbR and induced by SCB1
ScbR binds in vitro to the promoter regions of kasO, and
SCB1 prevents this binding. To determine the effect of
ScbR on kasO expression in vivo, S1 nuclease protection
analysis was conducted on RNA from M145 (parent),
M751 (DscbA) and M752 (DscbR). For time point 1 in
M145 and M752, the same RNA samples that had been
used in the microarray experiments (growth curve No. 2)
were used. In M145, kasO transcription was undetectable
during rapid growth, but was detected at transition phase,
and declined as the cultures entered stationary phase. In
contrast, in the scbR mutant, kasO expression was con-
stitutive throughout growth, while kasO transcripts were
not detected in the scbA mutant (Fig. 5A). These obser-
vations provided evidence that, in vivo, ScbR represses
kasO and that SCB1 produced via scbA relieves this
repression.
To test this hypothesis further, we also used S1
nuclease protection analysis to study the effect on
kasO expression  of  adding  chemically  synthesized
SCB1  at a final concentration of 31 ng ml-1 (128 mM) to
a mid-exponential phase (OD450 = 0.41) culture of
M751. RNA was isolated at 15 and 60 min after SCB1
addition. The RNA samples for no addition (time point
0) and 60 min after addition were the same samples
used in the microarray experiments. There was a
marked increase in the expression of kasO after the
addition of SCB1, similar to the level detected in the
parent (Fig. 5B). Thus, the relief of ScbR repression on
kasO expression observed in vivo requires SCB1 pro-
duced via scbA.
Expression of the cryptic polyketide cluster is dependent 
on kasO
The role of kasO as a pathway-specific regulatory
gene was determined by replacing most of the kasO
coding sequence with an apramycin resistant cassette,
yielding strain LW6. LW6 was constructed by the PCR
targeting method (Experimental procedures) and con-
firmed by Southern hybridizations and by PCR (data
not shown).
No obvious phenotype was detected with the kasO
mutant and as the final product of the polyketide gene
cluster is yet to be determined, expression of several
genes in the cluster was assessed by RT-PCR. RNA was
isolated from four different time points from LW6 grown in
SMM liquid media. Four samples of RNA isolated from
M145 for the expression studies of kasO was used for
comparison. cDNA was synthesized from 2 mg of RNA
(Experimental procedures) and cDNA equivalent to 0.1 mg
Fig. 5. Effects of mutations in scbA and scbR 
on kasO transcription.
A. S1 nuclease protection analysis of kasO and 
hrdB transcripts using RNA isolated from SMM 
liquid-grown cultures of S. coelicolor M145, 
M751 and M752. Numbers 1–8 denote the 
samples taken at OD450 (see Experimental pro-
cedures). The M145 and M752 RNA samples 
from time point 1 were the same as were used 
in Fig. 1, and for the microarray analysis (GC 
No. 2). E, TRAN and S indicate the exponential, 
transition and stationary phases of growth, 
respectively, and the shaded boxes labelled 
RED and A denote the production of undecyl-
prodigiosin and actinorhodin respectively.
B. S1 nuclease protection analysis of kasO and 
hrdB transcripts using RNA isolated from 
DscbA at time zero (–) (OD450 0.5), and 15 and 
60 min after addition of SCB1. The same RNA 
sample for 60 min after addition of SCB1 was 
used for microarray analysis (addition No. 2).
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RNA was used in each PCR with different primers
(Table 3). RNA was used as template for each primers as
negative control and M145 total DNA was used as tem-
plate for positive control.
While expression of the predicted biosynthetic genes,
SCO6273, 6276 and 6279, in the cryptic polyketide
cluster was detected in the parent at late transition
phase, no or very little (SCO6276) expression was
detected in LW6 (Fig. 6). A further 35 cycles of RT-PCR
failed to reveal expression of SCO6273 and SCO6279
(data not shown). Expression of scbR and scbA was
readily detected and effectively the same in both strains,
as was expression of hrdB (encoding the major sigma
factor for S. coelicolor). The expression profile of scbA
corresponded well to the S1 nuclease experiments.
However, expression of scbR was detected throughout
growth using RT-PCR, while temporal expression was
detected in the S1 nuclease experiments (Fig. 6). This
may reflect the enhanced sensitivity of RT-PCR, and
reflects the need for extensive controls when making
quantitative measurements. Nevertheless, the results
obtained with RT-PCR suggest strongly that kasO acti-
vates the expression of the cryptic polyketide gene clus-
ter and that it is a pathway-specific regulatory gene. The
negative controls showed no amplified product (data not
shown) while the positive controls showed amplified
products corresponding to the appropriate size for each
primer (Fig. 6).
Replacement of kasO with the apramycin cassette
may have had polar effect on the expression of the
downstream gene, SCO6281. If SCO6281 is co-tran-
scribed with kasO, then at this stage we cannot formally
exclude the possibility that a reduction in the SCO6281
(which appears to encode a FAD-binding protein)
expression might be responsible for the deficiency in
SCO6273, 6276, 6279 transcript, although this seems
unlikely.
Discussion
ScbR binds to the promoter region of a pathway-specific 
regulatory gene in a polyketide gene cluster
The use of newly available microarrays has led to the
discovery that the cryptic polyketide gene cluster of S.
Fig. 6. Expression of several genes in the cryptic polyketide antibiotic 
cluster compared in the parent and the kasO mutant. RT-PCR using 
cDNA synthesized from RNA isolated from the parent (equivalent to 
the RNA samples used in Fig. 5A, No. 2, 4, 6 and 8), and from the 
LW6 mutant. Numbers 1–4 denote samples taken at various OD450 
(see Experimental procedures). Amplified products are indicated on 
the right. The expected sizes of the amplified products are: SCO6273: 
1.04 kb; hrdB: 0.55 kb; SCO6279: 0.54 kb; SCO6276: 0.74 kb; scbR: 
0.49 kb; scbA: 0.48 kb. The template used for DNA positive control 
PCR was M145 total DNA for all primers. E, TRAN, and S indicate 
the exponential, transition and stationary phases of growth, respec-
tively, and the shaded boxes labelled RED and A denote the produc-
tion of undecylprodigiosin and actinorhodin respectively.
Table 3. List of primers used for RT-PCR experiments.
Primers Primer sequence 5¢-3¢a Fragment sizeb (bp) Amplified regionc
kasCrt1 gctcgacgaggcgtacgacaa 1040 SCO6273
kasCrt2 gcccgagccgcggcacgaaca
kasSrt1 gtgctctctccgagaccttcg 741 SCO6276
kasSrt2 gacttgatgaagccgatgaag
kasRrt1 cgtttctgctggaggtgctcg 540 SCO6279
kasRrt2 ccagctgttcctcgttcctgc
scbRrt1 caggatgtgcttctgcagcag 492 SCO6265 (scbR)
scbRrt2 gcaggtcttcgagaagcaggg
scbArt1 tctgcgtccgatgccaactcg 483 SCO6266 (scbA)
scbArt2 ggtagacttgaggactggtga
hrdBrt1 gagtccgtctctgtcatggcg 547 SCO5820 (hrdB)
hrdBrt2 tcgtcctcgtcggacagcacg
a. 5¢ to 3¢ primer sequences.
b. Size of PCR amplified product.
c. Description of the amplified promoter region. The SCO numbers are taken from the EMBL Accession No. AL645882. Gene names are also given.
In all cases, template was total DNA of M145.
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coelicolor is regulated by ScbR. We have identified a new
target for ScbR by in vitro and in vivo analysis as the
promoter region of kasO, shown to be a pathway-specific
regulatory gene by the effects of a kasO deletion on
expression of several genes of the pathway. In several g-
butyrolactone systems, there has been partial evidence to
suggest that a g-butyrolactone-binding protein regulates
the expression of pathway-specific regulatory genes
(Folcher et al., 2001; Stratigopoulos et al., 2002; Matsuno
et al., 2004). However, this appears to be the first report
to show that a g-butyrolactone-binding protein directly
represses a pathway-specific regulatory gene in an anti-
biotic biosynthesis gene cluster and that repression is
relieved by the cognate g-butyrolactone, leading to the
expression of the pathway-specific regulatory gene and
thus presumably to the expression of the antibiotic gene
cluster.
ScbR binds to two regions in the promoter of kasO: site
OA overlapping the -10 and -35 region of the trans-
criptional start site for kasO, and site OB at -222 nt to
-244 nt. Site OA shows high similarity to the previously
reported binding site R in the scbA/R promoter region
sequence, which also functions to promote repression
(Fig. 4D). On the other hand, site OB in the kasO pro-
moter region shows only limited similarity to the consen-
sus (ScbR bound to this site possibly binds to SCB1 less
strongly than when ScbR is bound to site OA). However,
there are no in vitro data at present to suggest that the
binding of ScbR to site OB plays a role in activating the
promoter,  as  may  be  the  case  for  binding  of  ScbR  to
the second target (site A) in the scbA promoter (Takano
et al., 2001).
There are reports where DNA binding sites were
found in vitro and yet did not seem to have an effect on
the expression of the genes in vivo (Kato et al., 2004).
While this may eventually turn out to be true for site OB
in the kasO promoter region, we did not observe any
difference in vitro in the specificity of ScbR for the two
binding sites by competition with unlabelled DNA frag-
ments or by changing the amount of ScbR added (data
not shown).
Further work will be needed to find out whether the
product of the scbR-like gene (SCO6286; Table 3) in the
polyketide cluster interacts with ScbR or binds to either of
the ScbR binding sites in the kasO promoter, either inde-
pendently of ScbR or in association with it.
The roles of ScbR and similar proteins in regulating 
secondary metabolism
The cryptic polyketide gene cluster contains at least three
putative regulatory genes. Two, kasO and SCO6288,
encode SARPs; while the other, SCO6286, is a homo-
logue of scbR (K. Pawlik et al., in preparation). Interest-
ingly, ScbR did not bind to the promoter regions of
SCO6288, SCO6286 or any of the biosynthetic genes in
the cluster: the sole target was the promoter region of
kasO.
The role of each regulatory protein in the polyketide
cluster is still to be determined by construction of appro-
priate mutants, and these experiments are hindered by
the lack of knowledge of the compound whose production
is directed by the cluster. The tylosin biosynthesis cluster
(which also involves type I PKS genes) has a similar array
of regulatory genes, notably two that encode SARP homo-
logues showing high similarity to kasO and SCO6288,
and two encoding g-butyrolactone-binding protein homo-
logues (Bate et al., 1999). Mutagenesis analysis by Bate
et al. (2002) showed that tylS (encoding a SARP similar
to that encoded by SCO6288) activates tylosin biosynthe-
sis via tylR, while the role of the other SARP, encoded by
tylT (a homologue of kasO), is not clear. tylP (a homo-
logue of scbR) appears to be the main regulatory gene
for tylosin biosynthesis and represses expression of both
tylQ (a homologue of SCO6286; also encoding an ScbR-
like protein) and tylS (Stratigopoulos and Cundliffe, 2002;
Stratigopoulos et al., 2002). It is clear from our study that
the details of the regulation of the polyketide gene cluster,
although it involves similar elements, are different from
those for the tyl cluster: if the second scbR-like gene has
any regulatory role, it is likely to be as part of a regulatory
cascade parallel to the one involving ScbR, rather than a
sequential one, as in the tylosin biosynthesis.
Recently, the nucleotide sequences of a considerable
number of gene clusters encoding the production of sec-
ondary metabolites have become available, including
many in the genome sequences of S. coelicolor (Bentley
et al., 2002) and Streptomyces avermitilis (Ikeda et al.,
2003). At least 18 genes encoding homologues of g-
butyrolactone-binding proteins out of 36 are located in
close proximity to antibiotic biosynthesis genes and have
been shown to regulate antibiotic production (Table 4). It
thus seems that g-butyrolactones are strongly associated
with the regulation of antibiotic production and that most
of the g-butyrolactone-binding proteins may well be
pathway-specific regulatory proteins. Perhaps the S. gri-
seus A-factor-binding protein, the first to be characterized
in detail, is atypical in that it regulates multiple pheno-
types, including morphological differentiation and the pro-
duction of a yellow pigment, in addition to streptomycin
production via AdpA; and ArpA does not appear to regu-
late pathway-specific regulatory genes directly (Kato
et al., 2004). It is noteworthy that g-butyrolactone receptor
protein homologues have also been found in non-
Streptomyces actinomycetes (Table 4), and that a recent
report by Choi et al. (2003) identified g-butyrolactones and
receptor proteins from non-Streptomyces actinomycetes
producing commercially important antibiotics. It will be
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interesting to determine whether those g-butyrolactones
are also involved in the regulation of antibiotic production.
Identification of further ScbR binding sites
SCB1 was identified by its ability to stimulate production
of Act and Red, the pigmented antibiotics produced by S.
coelicolor (Takano et al., 2001). We have reported previ-
ously the possibility of ScbR regulating the production of
Act and Red via a repressor for secondary metabolism.
We have found one target of ScbR from the DNA microar-
ray experiments described here. It is most probable that
kasO is not the repressor for general secondary metabo-
lism. However, the genes identified from the transcriptome
analysis include seven that are unlikely to be involved in
the synthesis of the polyketide that appears to be regu-
lated by kasO. They are located far from this cluster and
do not seem to be related to either potential precursor
biosynthesis or transport of the compound. We have also
shown in this report that ScbR cannot bind to the promoter
region of these genes. Whether ScbR binds to the pro-
moters of any other genes that in turn control the expres-
sion of these seven genes and also perhaps of Act and
Red is yet to be determined. However, when DNA
sequences homologous to the ScbR binding consensus
sequence deduced from the two repressor sites were
sought in the whole genome sequence of S. coelicolor,
one such sequence (AACCGGNNNNNNGGTTTGT) was
found in the promoter region of orfB (SCO6268), encoding
a homologue of histidine protein kinases, one gene away
from scbA. Further experiments are in progress to deter-
mine whether ScbR regulates orfB, and the effect, if any,
of orfB on the expression of the seven unlinked genes
identified by microarray analysis and on the expression of
Act and Red biosynthesis genes.
This report explores one aspect of the microarray data,
by using them as a preliminary guide to find the key target
of ScbR in the polyketide gene cluster. Further microarray
analysis using the scbR and scbA mutants at different
time points of growth is in progress to analyse more sys-
Table 4. List of ScbR homologues from the EMBL data base.
Gene names/accession No. Organism Amino acid identitya Reference
bScbR/NP-630365 S. coelicolor 100% Takano et al. (2001)
FarA/BAA21859 S. lavendulae 57% Waki et al. (1997)
Orf82/NP-851504 S. rochei (plasmid pSLA2-L) 51% Mochizuki et al. (2003)
cAlpZ/AAR30170 S. ambofaciens 48% Pang et al. 2004
BarA/A57507 S. virginiae 47% Kinoshita et al. (1997)
AvaR/NP-824882 S. avermitilis MA-4680 47%
TarA/AAF06961 S. tendae 48% Engel et al. (2001)
SabR/AAP8737 S. ansochromogenes 48% Li et al. (2003)
SctR/BAC66444 S. clavuligerus 48% Kim et al. (2004)
SpbR/AAK07686 S. pristinaespiralis 48% Folcher et al. (2001)
TylP/T44586 S. fradiae 45% Bate et al. (1999)
ArpA/BAA08617 S. griseus 41% Onaka et al. (1995)
KsbA/BAD20229 Kitasatospora setae 38% Choi et al. (2004)
AAM78022 S. carzinostaticus ssp. neocarzinostaticus 39%
AAR90230 Rhodococcus sp. DK17 (plasmid PKD3) 34%
SAV3702/NP-824879 S. avermitilis MA-4680 33%
BarB/BAA23612 S. virginiae 37% Kinoshita et al. (1997)
Orf79/NP-851501 S. rochei (plasmid pSLA2-L) 34% Mochizuki et al. (2003)
MmfR/NP-639852 S. coelicolor (plasmid SCP1) 30%
AplW/AAR30167 S. ambofaciens 31% Pang et al. (2004)
TylQ/T44588 S. fradiae 35% Bate et al. (1999)
SCO6286/NP-630384 S. coelicolor 32%
Orf74/NP-851496 S. rochei (plasmid pSLA2-L) 34% Mochizuki et al. (2003)
CprB/NP-630180 S. coelicolor 32% Onaka et al. (1998)
MAP0928/NP-959902 Mycobacterium avium ssp. paratuberculosis str. k10 32%
SCO6323/NP-630417 S. coelicolor 29%
CprA/NP-630409 S. coelicolor 32% Onaka et al. (1998)
SAV2270/NP-823446 S. avermitilis MA-4680 31%
ZP 00158065 Anabaena variablilis ATCC29413 30%
JadR2/AAB36583 S. venezuelae 29% Yang et al. (1995)
SAV2268/NP823444 S. avermitilis MA-4680 33%
PBD2.026/NP-898641 Rhodococcus erythropolis (plasmid pBD2) 28%
Alr4567/NP-488607 Nostoc sp. PCC 7120 30%
AAR90230 Rhodococcus sp. DK17 (plasmid PKD3) 32%
CprA MAP0969/NP-959903 M. avium ssp. paratuberculosis str. k10 28%
BarZ/BAA96295 S. virginiae 34% Kawauchi et al. (2000)
a. Amino acid identity with ScbR from BLAST searches performed at NCBI (http://www.ncbi.nlm.nih.gov).
b. Bold gene names denote those previously shown to cluster with antibiotic biosynthesis genes and regulate production of the cognate antibiotics.
c. Grey gene names represent those located in an antibiotic biosynthesis gene cluster.
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tematically and to extend the genes that are controlled by
the SCB signalling molecules.
Experimental procedures
Bacterial strains, plasmids and growth conditions
Streptomyces coelicolor A3(2) strains M145 (Kieser et al.,
2000), M751, M752 (Takano et al., 2001) and LW6 (this
study) were manipulated as previously described (Kieser
et al., 2000). E. coli K-12 strains JM101 (Sambrook et al.,
1989) and ET12567 (MacNeil et al., 1992) were grown and
transformed according to Sambrook et al. (1989). Vectors
used were pIJ2925, pKC1132, pSET152 (Kieser et al.,
2000), pBluescript SK+ (Stratagene) and pDrive (Qiagen).
pTE1 was constructed by cloning the kasO F+R (Fig. 4A; see
Table 2 for primer sequences) PCR product into pDrive. SMM
was as reported by Takano et al. (2001). SMMS is the agar
(1.5%, w/v) version of the modified SMM. MS agar (Kieser
et al., 2000) was used to grow cultures for preparing spore
suspensions, and for plating out intergeneric conjugations of
Streptomyces strains with E. coli ET12567 containing the
RP4 derivative pUZ8002 (Flett et al., 1997).
RNA procedures, including microarray analysis and S1 
nuclease protection analysis
RNA was isolated as described in Kieser et al. (2000)
except that for microarray analysis samples were further
purified by double chloroform extraction and eluted through
an RNeasy column (Qiagen Cat. No. 75142). Samples for
microarray analysis were harvested from SMM at OD450 0.5
(14.0 h) for M145 and 0.46 (14.0 h) for M752 for growth
curve No. 1 (GC1), and OD450 0.38 (15.5 h) for M145 and
0.37 (15.5 h) for M752 for growth curve No. 2 (GC2). SCB1
was added to M751 at OD450 0.41 (addition No. 1) and 0.41
(addition No. 2). S. coelicolor microarray (SC3, 4) design
and production are described in Chater et al. (2002). SC3
arrays contained ª6500 good (successful PCR) probes and
the SC4 arrays 7333. In this article results from some SC4s
are presented. Hybridization, wash conditions, scanning
and image analysis were as described in Bucca et al.
(2003) and http://www.surrey.ac.uk/SBMS/Fgenomics. Cy-3
labelled scbR mutant cDNA or parent M145 cDNA from
time point 1 representing exponential growth was hybridized
to the microarrays together with Cy-5 labelled M145
genomic DNA, or, in the case of SCB1 addition, time zero
cDNA labelled with Cy-5 was compared with Cy-3 labelled
cDNA from RNA isolated 60 min after SCB1 addition.
Hybridizations were conducted in duplicate with each of the
duplicate cDNA samples. After scanning with an Affymetrix
428 array scanner, the 16-bit TIFF images were processed
with Imagene 4.2 software (BioDiscovery). Array data were
analysed using GeneSpring (version 4.2, Silicon Genetics).
Normalization was performed per spot: divide by control
channel, per chip: normalize to 50th percentile. The statisti-
cal analysis tool in GeneSpring was used for further analy-
sis and used a parametric test with global error model
variances. This tool omitted any data with P-values of more
than 0.05.
For each S1 nuclease reaction, 30 or 40 mg of RNA was
hybridized in NaTCA buffer [Murray, 1986; solid NaTCA
(Aldrich) dissolved to 3 M in 50 mM PIPES, 5 mM EDTA,
pH 7.0] to about 0.002 pmol (approximately 104 Cerenkov
counts min-1) of the probes. To map the transcriptional
start site of kasO, the oligonucleotide ksOR 5¢-GTTGGC
CTGCAACAGCAGGTA (which anneals within the kasO
coding region) was uniquely labelled at the 5¢-end with
[32P]-ATP using T4 polynucleotide kinase, and used in PCR
with the unlabelled oligonucleotide ksOF 5¢-GTGTATGT
CACGGACGAGGAG (which anneals upstream of the kasO
promoter) and cosmid SC1G7 DNA as template, to gener-
ate a 522 bp probe. For hrdB (Aigle et al., 2000) and
scbR/A (Takano et al., 2001) the probes were made as
previously described. Subsequent steps were as described
by Strauch et al. (1991). RNA were isolated from liquid
SMM-grown cultures of S. coelicolor M145 (parent), M751
(DscbA) and M752 (scbR) at OD450 of: (1) 0.36, 0.4, 0.39
(M145: 15.5 h, M751: 14.5 h, M752: 15.5 h), (2) 0.57, 0.53,
0.56 (17.0 h, 17.5 h, 17.4 h), (3) 0.78, 0.78, 0.79 (19.0 h,
19.0 h, 19.6 h), (4) 0.88, 0.84, 0.87 (20.5 h, 21.0 h,
21.4 h), (5) 1.04, 0.91, 1.0 (22.5 h, 22.0 h, 22.6 h), (6)
1.10, 0.92, 0.96 (23.5 h, 22.5 h, 24.4 h), (7) 1.12, 0.98,
1.14 (25.0 h, 23.0 h, 26.4 h), and (8) 1.10, 1.20, 1.28
(42 h, 42 h, 42 h).
Gel retardation assays and DNase I footprinting studies
For gel retardation experiments, oligonucleotides shown in
Table 2 were used to generate PCR fragments for the corre-
sponding gene promoter regions. Fragments were then
labelled using a DIG Gel Shift Kit (Roche cat No. 1635352).
Gel retardation, using ScbR-containing extracts from an E.
coli overexpression construct, was carried out using the con-
ditions described in Takano et al. (2001). In some cases, 1 mg
of SCB1 or one of its stereoisomers was added before incu-
bation and the mixture incubated for a further 10 min. Blotting
and detection of the membrane was performed according to
the manufacturer’s conditions.
For DNase I footprinting studies, 50 pmol of oligonucleotide
A1 and 4 (Fig. 4A; Table 1) were uniquely labelled on their 5¢
ends with [32P]-ATP using T4 polynucleotide kinase and used
in PCR with unlabelled oligonucleotide A1 and 4, respec-
tively, with cosmid SC1G7 (Redenbach et al., 1996) as a
template, to generate a 434 bp DNA fragment. DNase I foot-
printing conditions were as described in Takano et al. (2001).
In some cases, 1 mg of SCB1 was added to the reaction
mixture before incubation and the mixture incubated for a
further 10 min. Sequencing reactions were performed with
the oligonucleotides used to amplify the PCR fragments as
primers with pTE1 DNA as template, and using a dideoxy
sequencing kit (Sequenase 7-deaza-dGTP DNA sequencing
Kit, USB, product No. 70990).
Construction of a deletion mutant of kasO
A mutant kasO allele was constructed in which most of the
kasO coding region (amino acids 17–530 out of 543) was
deleted and replaced with an apramycin resistance gene
using PCR targeting. Primers (5¢-CGGATGCTCGGTCCAC
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with 5¢ ends overlapping the 5¢ and 3¢ ends of the kasO
coding sequence, and 3¢ (priming) ends were designed to
amplify the apramycin resistance disruption cassette of
pIJ773 (Gust et al., 2004). The mutant was constructed as
described in Takano et al. (2003), except that the cosmid
used to introduce the mutation into Streptomyces was
SCAH10 (Redenbach et al., 1996). Deletions within kasO
were confirmed by Southern hybridization (Kieser et al.,
2000) using a PCR-generated probe (labelled with DIG DNA
labelling kit, Roche) and also by PCR. Two independent col-
onies were isolated and one was designated LW6.
RT-PCR
RT-PCR was conducted using RNA isolated from LW6 grown
in SMM liquid medium at four different time points: OD450 at:
(1) 0.34 (17 h), (2) 0.54 (19 h), (3) 0.72 (21.5 h, produced
Red) and (4) 0.90 (25 h) during the growth phase. RNA
isolated for S1 nuclease protection analysis from M145 from
time points (2) 0.57 (17.0 h) and (4) 0.88 (20.5 h), (6) 1.10
(23.5 h) and (8) 1.10 (42 h) was also used. cDNA was syn-
thesized by following a protocol used for generating cDNA for
microarray analysis. 2 mg of RNA was mixed with 0.34 ml of
Random primers (Invitrogen) with dH2O to a final volume of
15 ml, incubated at 70∞C for 10 min and placed on ice. Six
microlitres of 5¥ buffer (Invitrogen), 3 ml of DTT, 3 ml of dNTP
mix (100 mM each), 2 ml of dH2O were mixed with 1 ml of
Superscript II (Invitrogen) and incubated at 25∞C for 10 min,
37∞C for 5 min, 42∞C for 70 min to synthesize cDNA. One
microlitre of the cDNA (equivalent to 0.1 mg of RNA) was
used as template per PCR. PCR was conducted using Taq
polymerase from Roche using the manufacturer’s conditions
(using Q buffer and dNTP with a final concentration of
200 mM). The programme was as follows: (1) 95∞C, 5 min, (2)
95∞C, 45 s, (3) 68∞C, 45 s, (4) 72∞C, 45 s, and (5) 72∞C, 5 min
repeating the two to four steps for either 20 cycles or 35
cycles. For negative control, RNA (1–2 mg) was used as
template and for positive control, M145 total DNA (0.1 mg)
was used as template.
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